Literature DB >> 19021539

Mechanism of the metal-mediated endocytosis of the prion protein.

Nigel M Hooper1, David R Taylor, Nicole T Watt.   

Abstract

The cellular form of the prion protein, PrP(c), is critically required for the establishment of prion diseases, such as Creutzfeldt-Jakob disease. Within the N-terminal half of PrP(c) are four octapeptide repeats that bind Cu(2+). Exposure of neuronal cells expressing PrP(c) to Cu(2+) results in the rapid endocytosis of the protein. First, PrP(c) translocates laterally out of detergent-resistant lipid rafts into detergent-soluble regions of the plasma membrane, then it is internalized through clathrin-coated pits. The extreme N-terminal region of PrP(c) is critically required for its endocytosis, as is the transmembrane LRP1 (low-density lipoprotein receptor-related protein-1). Incubation of cells with a competitive inhibitor of LRP1 ligands, receptor-associated protein, or down-regulation of LRP1 with siRNA (short interfering RNA) reduces the endocytosis of PrP(c). Zn(2+) also promotes the endocytosis of PrP(c), a phenomenon that is also dependent on the octapeptide repeats and requires LRP1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021539     DOI: 10.1042/BST0361272

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  16 in total

1.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

2.  An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity.

Authors:  Isaac H Solomon; Natasha Khatri; Emiliano Biasini; Tania Massignan; James E Huettner; David A Harris
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

3.  Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.

Authors:  Ann R Spevacek; Eric G B Evans; Jillian L Miller; Heidi C Meyer; Jeffrey G Pelton; Glenn L Millhauser
Journal:  Structure       Date:  2013-01-03       Impact factor: 5.006

Review 4.  Transition of the prion protein from a structured cellular form (PrPC ) to the infectious scrapie agent (PrPSc ).

Authors:  Pravas K Baral; Jiang Yin; Adriano Aguzzi; Michael N G James
Journal:  Protein Sci       Date:  2019-10-25       Impact factor: 6.725

5.  Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.

Authors:  Dustin P Martin; Vellareddy Anantharam; Huajun Jin; Travis Witte; Robert Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2011-08-19       Impact factor: 4.294

6.  In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Authors:  Bonto Faburay; Dongseob Tark; Anumantha G Kanthasamy; Juergen A Richt
Journal:  Prion       Date:  2014       Impact factor: 3.931

7.  Interaction between Prion Protein's Copper-Bound Octarepeat Domain and a Charged C-Terminal Pocket Suggests a Mechanism for N-Terminal Regulation.

Authors:  Eric G B Evans; M Jake Pushie; Kate A Markham; Hsiau-Wei Lee; Glenn L Millhauser
Journal:  Structure       Date:  2016-06-02       Impact factor: 5.006

Review 8.  Gene expression resulting from PrPC ablation and PrPC overexpression in murine and cellular models.

Authors:  Franc Llorens; Isidre Ferrer; José Antonio del Río
Journal:  Mol Neurobiol       Date:  2013-08-16       Impact factor: 5.590

Review 9.  Cell biology of prion strains in vivo and in vitro.

Authors:  Daniel Shoup; Suzette A Priola
Journal:  Cell Tissue Res       Date:  2022-02-02       Impact factor: 5.249

Review 10.  Endocytosis of glycosylphosphatidylinositol-anchored proteins.

Authors:  Shaheen E Lakhan; Shefali Sabharanjak; Ananya De
Journal:  J Biomed Sci       Date:  2009-10-15       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.